CALCIUM PYROPHOSPHATE
Bases de datos vinculadas 18 · 대한화장품협회 성분사전, 미국 CIR 안전성 평가, 미국 EPA 화학물질 DB, 미국 EPA CompTox +14
Definición
Calcium diphosphate is a calcium phosphate. It contains a diphosphate(4-).
출처: PubChem
미국 FDA 물질 등록 · UNII X69NU20D19 · 등록명 CALCIUM PYROPHOSPHATE · 단일 화학물질
이 원료는 다음의 구조를 갖는 무기염이다.
출처: 식약처 화장품 원료성분
Nombres y definiciones oficiales
JCIA 표시명 リン酸(Ca/セリウム): 本品は、炭酸Ca(*)、ピロリン酸カルシウム及びセリウムの焼成物である。
출처: 일본 화장품공업연합회 표시명
Nombres e identificadores
- CAS No.número de registro químico
- 7790-76-3
- EC No.número de inventario químico de la UE
- 232-221-5
- DTXSIDidentificador químico de la EPA (EE. UU.)
- DTXSID50872512
- DTXCIDidentificador de compuesto de la EPA (EE. UU.)
- DTXCID40820163
- IUPAC
- Dicalcium diphosphate
- 분자식
- Ca2O7P2
- 분자량
- 254.097 g/mol
Propiedades medidas
- 성상
- Dry Powder · A fine, white, odourless powder
- 녹는점
- 1353 °C
- 용해성
- Insoluble in water. Soluble in dilute hydrochloric and nitric acids · Sol in dil hydrochloric and nitric acids, practically insol in water
- 밀도
- 3.09
- pH
- Between 5,5 and 7,0 (10 % suspension in water)
- 색상
- 백색
- 녹는점/어는점
- 1353 ℃
- 용해도
- (불수용성, 염산, 질산에 용해)
- 비중
- 3.09
- 분자량
- 254.10
물질 자체를 측정한 값입니다. 안전보건공단 자료는 MSDS 작성·검토 참고용이며, 원료 상품의 규격은 아닙니다.
Funciones cosméticas
Referencias de seguridad y regulación
국내 유독물 GHS 분류 없음 · 기존화학물질
Other restriction: ban substances that deplete the ozone layer
출처: EU CosIng 성분 목록
Reviewed by CIR: Safety Assessment of Phosphoric Acid and Its Salts as Used in Cosmetics
출처: 미국 CIR 안전성 평가
Literatura relacionada
- P028 Crowned dens syndrome: a rare yet important-to-recognise phenotype of calcium pyrophosphate crystal deposition disease · 2025
- Concurrent Post-Zoster Cutaneous Vasculitis and Acute Calcium Pyrophosphate Deposition Disease (CPPD) in an Elderly Patient: A Case Report · 2024
- THU0419 BIOLOGICS IN THE TREATMENT OF CALCIUM PYROPHOSPHATE DEPOSITION DISEASE. A SYSTEMATIC LITERATURE REVIEW · 2020
- Acute calcific tendinitis of gluteus maximus tendon due to tumoral calcium pyrophosphate dihydrate deposition disease · 2017
- Coincidence of monosodium urate monohydrate, calcium pyrophosphate dihydrate, and basic calcium phosphate crystals in the synovial fluid from a single joint · 2016
Para qué lo usan los productos
미국 EPA에 이 성분을 신고한 제품 6건의 용도입니다. 화장품 밖의 제품도 포함되어 있어, 위쪽 몇 줄이 이 성분의 주된 쓰임으로 읽힌다는 뜻입니다.
- 연마제3
- 충전제1
- 착향·영양1
- 안정화제1
출처: 미국 EPA CompTox
Estudios de irritación y sensibilización
피부 시험 2건 · 눈 시험 4건이 기록되어 있습니다.
시험 결론이 대체로 일치합니다(100%). 원료 자체를 시험한 기록이고, 완제품에 든 농도에서의 자극성과는 다릅니다.
시험 6건 전부 보기
- Studies Indicate No Significant Irritation
skin corrosion: in vitro / ex vivo · Screening · EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test) according to OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method) according to - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation) - Studies Indicate No Significant Irritation
eye irritation: in vitro / ex vivo · Screening · OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying Ocular Corrosives and Severe Irritants) [before 26 July 2013] according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) 2012 according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to - Ambiguous
eye irritation: in vitro / ex vivo · Screening · OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying Ocular Corrosives and Severe Irritants) [before 26 July 2013] according to EU method B.47 (Bovine corneal opacity and permeability test method for identifying ocular corrosives and severe irritants) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to
출처: 미국 EPA CompTox